Needle-Free DNA vaccines aim to stop deadly Rodent-Borne viruses
NCT ID NCT04333459
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested two DNA vaccines designed to prevent hemorrhagic fever with renal syndrome caused by Hantaan and Puumala viruses. A total of 132 healthy adults received up to four doses of vaccine using a needle-free jet injector. The main goal was to see if the vaccines triggered a strong immune response, especially at a lower dose for the Hantaan vaccine.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HANTAAN VIRUS NEPHROPATHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Trials Center, Walter Reed Army Institute of Reserach
Silver Spring, Maryland, 20910, United States
-
Department of Clinical Trials, WRAIR
Silver Spring, Maryland, 20910, United States